We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
-15.75%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$4.54B
AUM Growth
-$1.27B
Cap. Flow
-$395M
Cap. Flow %
-8.71%
Top 10 Hldgs %
42.65%
Holding
327
New
47
Increased
54
Reduced
101
Closed
69

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$151M
2
DGX icon
Quest Diagnostics
DGX
+$135M
3
VISN
Vistance Networks Inc
VISN
+$95.6M
4
TXT icon
Textron
TXT
+$81.1M
5
CVS icon
CVS Health
CVS
+$72M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$161M
2
NOK icon
Nokia
NOK
+$112M
3
PCG icon
PG&E
PCG
+$94.2M
4
GD icon
General Dynamics
GD
+$93.3M
5
PFE icon
Pfizer
PFE
+$88.2M

Sector Composition

Rank Sector Weight
1 Financials 19.01%
2 Healthcare 14.48%
3 Technology 13.44%
4 Consumer Discretionary 10.93%
5 Consumer Staples 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CZR
326
DELISTED
Caesars Entertainment Corporation
CZR
– –
-10,000
Closed -$102K
10 11 12 13
14

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return

Levin Capital Strategies's Q4 2018 Portfolio in Review

As of Q4 2018, Levin Capital Strategies held 327 positions worth $4.54B, down 22% from $5.81B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Levin Capital Strategies withdrew a net $395M in Q4 2018, closing 69 positions and reducing 101 holdings. Its most notable exit was General Dynamics, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Levin Capital Strategies opened a new position in Quest Diagnostics worth $120M.

  • Levin Capital Strategies's largest Q4 2018 buy was Quest Diagnostics: 1,438,145 shares worth $120M.
  • Levin Capital Strategies added most to Bio-Rad Laboratories Class A in Q4 2018, an estimated $151M increase.
  • Levin Capital Strategies's biggest Q4 2018 reduction was Merck, cutting an estimated $161M.
  • Levin Capital Strategies fully exited General Dynamics in Q4 2018, selling an estimated $93.3M.
  • Levin Capital Strategies's ten largest holdings make up 43% of its $4.54B portfolio in Q4 2018.
  • Levin Capital Strategies opened 47 new positions and closed 69 in Q4 2018.
  • Levin Capital Strategies's portfolio value fell 22% quarter-over-quarter to $4.54B.

Based on Levin Capital Strategies's 13F filing for Q4 2018, filed 5 Feb 2019.